DSIP is not approved by the FDA or EMA for any indication
While there is promising anecdotal evidence and some studies suggesting the benefits of IV therapy in immune support and inflammation management, it is essential to approach this treatment as part of a comprehensive care plan
Sourcing & Quality BPC-157 is available from Purgo Labs with third-party COA verification and research-grade purity standards
Selective stimulation of leukemic vs normal cells in myeloid leukemia by recombinant human growth factors (GF) assayed by chromosome-specific fluorescence in situ hybridization (FISH)
The BPC-157/TB-500 blend is utilized in controlled laboratory research settings for applications such as: At Pure Health Peptides, transparency is key
Their studies have documented BPC-157s effects across a remarkably broad range of tissue injury models including tendon, ligament, muscle, bone, and gastrointestinal lesions in rodent systems